cardiac monitoring device News
-
iRhythm builds case for wearable cardiac monitor with data in fainting, TAVR patients
iRhythm Technologies has presented new data on its Zio wearable cardiac monitoring device at the American College of Cardiology (ACC) 71st Annual Scientific Session & Expo, building the clinical case for its devices. One study used Zio AT for monitoring patients who were taken to hospital after fainting. By using the device to monitor patients after discharge, the physicians reduced ...
-
Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today reported it has received 510(k) clearance from the U.S. Food and Drug ...
-
Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device
Announcement follows FDA clearance Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it is now taking pre-orders for Biotres, the Company’s three-lead device designed to continuously record ...
-
Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022. The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since ...
-
Bardy Diagnostics Announces CE Mark Certification for 14-Day Carnation Ambulatory Monitor (CAM™) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis
SEATTLE, May 26, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received CE mark certification for the 14-Day version of the Carnation Ambulatory Monitor (“CAM”) patch, the industry’s only P-wave centric ambulatory cardiac patch monitor and ...
-
Pro-PLUS cardiomonitoring for young patients of Children’s Hospital in Bialystok
Cardiac arrhythmias affect not only adults, but unfortunately also children struggle with such health problems. It is for little patients that the K.I.D.S. Foundation announced a competition "Telemedicine in Children's Hospitals of the Future". One of the winning projects of this competition is the project "TeleFriends from the Heart" submitted by the University Children's Hospital in Bialystok, ...
By Pro-PLUS SA
-
Bardy Diagnostics Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine
Seattle, WA — March 25, 2020 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that its Carnation Ambulatory Monitor (“CAM™”) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have been prescribed Hydroxychloroquine ...
-
Professor Gust H. Bardy, M.D. of Bardy Diagnostics Partners with Arrhythmia Alliance to Increase Patient Awareness of Heart Arrhythmias and Early Detection
(Seattle, WA – November 17, 2020) – Chief Medical Officer of Bardy Diagnostics and Clinical Professor of Medicine University of Washington Professor Gust H. Bardy sat down with Trudie Lobban, MBE, Founder and CEO of Arrhythmia Alliance, a non-profit organization dedicated to improving the diagnosis, treatment, and quality of life for all those affected by arrhythmias, to discuss the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you